[
  {
    "ts": null,
    "headline": "Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q2 2025 Update",
    "summary": "William von Muefflingâs Cantillon Capital grew to $17.34B by smartly balancing high-conviction stocks, trimming gains, and maintaining focus. See more here.",
    "url": "https://finnhub.io/api/news?id=cb616f1ef6b600f8834bcf920e96d1634dc4495a23724ab92e69fd07bf96abaf",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754434423,
      "headline": "Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q2 2025 Update",
      "id": 136230428,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "William von Muefflingâs Cantillon Capital grew to $17.34B by smartly balancing high-conviction stocks, trimming gains, and maintaining focus. See more here.",
      "url": "https://finnhub.io/api/news?id=cb616f1ef6b600f8834bcf920e96d1634dc4495a23724ab92e69fd07bf96abaf"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis CFO talks Q2 beat & education's role in pet med adoption",
    "summary": "Zoetis (ZTS) stock is in focus after reporting earnings. Zoetis CFO Wetteny Joseph joins Market Catalysts to discuss the earnings print, the company's outlook and opportunity, and macro factors like tariffs and labor market conditions. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=20cd6c0ed9665510eefafcd5b2f0017f294021bf24b3cb1cf633ff20a4f1bc72",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754420400,
      "headline": "Zoetis CFO talks Q2 beat & education's role in pet med adoption",
      "id": 136217286,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis (ZTS) stock is in focus after reporting earnings. Zoetis CFO Wetteny Joseph joins Market Catalysts to discuss the earnings print, the company's outlook and opportunity, and macro factors like tariffs and labor market conditions. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=20cd6c0ed9665510eefafcd5b2f0017f294021bf24b3cb1cf633ff20a4f1bc72"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Inc. (ZTS): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Zoetis Inc. on Bob’s Payment Stock Substack by Bob Hammel. In this article, we will summarize the bulls’ thesis on ZTS. Zoetis Inc.’s share was trading at $151.81 as of August 4th. ZTS’s trailing and forward P/E were 27.25 and 24.57, respectively according to Yahoo Finance. Zoetis remains a dominant […]",
    "url": "https://finnhub.io/api/news?id=d8c89af22dbdc1369e5820b80aef6dd6926cf5866f304edf65c4aeae5a8862ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754416588,
      "headline": "Zoetis Inc. (ZTS): A Bull Case Theory",
      "id": 136217177,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Zoetis Inc. on Bob’s Payment Stock Substack by Bob Hammel. In this article, we will summarize the bulls’ thesis on ZTS. Zoetis Inc.’s share was trading at $151.81 as of August 4th. ZTS’s trailing and forward P/E were 27.25 and 24.57, respectively according to Yahoo Finance. Zoetis remains a dominant […]",
      "url": "https://finnhub.io/api/news?id=d8c89af22dbdc1369e5820b80aef6dd6926cf5866f304edf65c4aeae5a8862ef"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Zoetis Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=355b0826e0e75e84c55ce00d37598250d436978926e864f7c2a2bc5619b20009",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754412300,
      "headline": "Zoetis Inc. stock underperforms Tuesday when compared to competitors",
      "id": 136255106,
      "image": "",
      "related": "ZTS",
      "source": "MarketWatch",
      "summary": "Zoetis Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=355b0826e0e75e84c55ce00d37598250d436978926e864f7c2a2bc5619b20009"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Reverses And Dives As Its Arthritis Setback Continues",
    "summary": "Zoetis Reverses And Dives As Its Arthritis Setback Continues",
    "url": "https://finnhub.io/api/news?id=7d7ede196c8cdde3c244b94eb2ef689e3f14d8446a1a48deb447628ddf07c57d",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754410888,
      "headline": "Zoetis Reverses And Dives As Its Arthritis Setback Continues",
      "id": 136255086,
      "image": "",
      "related": "ZTS",
      "source": "DowJones",
      "summary": "Zoetis Reverses And Dives As Its Arthritis Setback Continues",
      "url": "https://finnhub.io/api/news?id=7d7ede196c8cdde3c244b94eb2ef689e3f14d8446a1a48deb447628ddf07c57d"
    }
  },
  {
    "ts": null,
    "headline": "ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised",
    "summary": "Zoetis posts better-than-expected Q2 results with rising sales of pet medicines, boosting its 2025 outlook.",
    "url": "https://finnhub.io/api/news?id=a7a30590451c2f3b74b749221a177e6cab16bc1b75706e4909bbf0abaaf92132",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754410860,
      "headline": "ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised",
      "id": 136215149,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis posts better-than-expected Q2 results with rising sales of pet medicines, boosting its 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=a7a30590451c2f3b74b749221a177e6cab16bc1b75706e4909bbf0abaaf92132"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline",
    "summary": "Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a second-quarter 2025 adjusted earnings per share of $1.76, up from $1.56 a year ago, beating the consensus of $1.61. The company reported sales of $2.50 billion, up 4% year over year, beating the consensus of $2.41 billion. On an organic operational basis, revenue for the second quarter of 2025 increased 8% compared with the second quarter of 2024. Revenue in the U.S. segment was $1.4 billion, up 4% and 7% on an organic operational b",
    "url": "https://finnhub.io/api/news?id=662737b4b829d26df906b7efbe91d5d88a0864a455ab1618b31ca7ba24e5b7a9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754405409,
      "headline": "Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline",
      "id": 136215150,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a second-quarter 2025 adjusted earnings per share of $1.76, up from $1.56 a year ago, beating the consensus of $1.61. The company reported sales of $2.50 billion, up 4% year over year, beating the consensus of $2.41 billion. On an organic operational basis, revenue for the second quarter of 2025 increased 8% compared with the second quarter of 2024. Revenue in the U.S. segment was $1.4 billion, up 4% and 7% on an organic operational b",
      "url": "https://finnhub.io/api/news?id=662737b4b829d26df906b7efbe91d5d88a0864a455ab1618b31ca7ba24e5b7a9"
    }
  },
  {
    "ts": null,
    "headline": "Stocks See Support from Strong Earnings and Rate Cut Speculation",
    "summary": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.20%. September E-mini S&P futures (ESU25 ) are up +0.15%, and September E-mini Nasdaq futures...",
    "url": "https://finnhub.io/api/news?id=a9d281e3b80f3e33180613ef2e96fe1ecb77140033ef9c6f16a67bb2d0afc822",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754402339,
      "headline": "Stocks See Support from Strong Earnings and Rate Cut Speculation",
      "id": 136215010,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.20%. September E-mini S&P futures (ESU25 ) are up +0.15%, and September E-mini Nasdaq futures...",
      "url": "https://finnhub.io/api/news?id=a9d281e3b80f3e33180613ef2e96fe1ecb77140033ef9c6f16a67bb2d0afc822"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis (ZTS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates",
    "summary": "The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
    "url": "https://finnhub.io/api/news?id=b48db85d823489498bdb3bec567f813c297ae7ff57c06f9abf724ae606bb7fad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754400605,
      "headline": "Zoetis (ZTS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates",
      "id": 136215153,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
      "url": "https://finnhub.io/api/news?id=b48db85d823489498bdb3bec567f813c297ae7ff57c06f9abf724ae606bb7fad"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Surges After Crushing Expectations And Raising Its Outlook",
    "summary": "Zoetis stock surged early Tuesday after the animal-health company beat quarterly forecasts, leading to a guidance hike.",
    "url": "https://finnhub.io/api/news?id=2397c9959247cd3f87a1bfa4df26049c7961ddcbf9c3f14c55697ce16a6576fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754398911,
      "headline": "Zoetis Surges After Crushing Expectations And Raising Its Outlook",
      "id": 136212543,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis stock surged early Tuesday after the animal-health company beat quarterly forecasts, leading to a guidance hike.",
      "url": "https://finnhub.io/api/news?id=2397c9959247cd3f87a1bfa4df26049c7961ddcbf9c3f14c55697ce16a6576fa"
    }
  },
  {
    "ts": null,
    "headline": "Animal healthcare firm Zoetis raises annual forecast on strong pet product demand",
    "summary": "Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and vaccines for pets, sending the animal healthcare company's shares surging about 9% in premarket trading. Analysts remain optimistic about the long-term prospects for the animal health industry, citing a rebound in veterinary clinic visits over the coming years as pet ownership grows and aging animals require chronic care treatments. The New Jersey-based company expects 2025 revenue to be between $9.45 billion and $9.60 billion, compared with its earlier range of $9.43 billion to $9.58 billion.",
    "url": "https://finnhub.io/api/news?id=16460c1ad3d7b2209279cd06afbd74365e6524e606a3f8e7cf2cbb2bca65d701",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754396655,
      "headline": "Animal healthcare firm Zoetis raises annual forecast on strong pet product demand",
      "id": 136212544,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and vaccines for pets, sending the animal healthcare company's shares surging about 9% in premarket trading. Analysts remain optimistic about the long-term prospects for the animal health industry, citing a rebound in veterinary clinic visits over the coming years as pet ownership grows and aging animals require chronic care treatments. The New Jersey-based company expects 2025 revenue to be between $9.45 billion and $9.60 billion, compared with its earlier range of $9.43 billion to $9.58 billion.",
      "url": "https://finnhub.io/api/news?id=16460c1ad3d7b2209279cd06afbd74365e6524e606a3f8e7cf2cbb2bca65d701"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Inc. 2025 Q2 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Zoetis Inc.",
    "url": "https://finnhub.io/api/news?id=2b98da46aa6a92bfecb7ef6d510d38a3afff04b46d1d6a2d3b0acafd2ad10d61",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754396453,
      "headline": "Zoetis Inc. 2025 Q2 - Results - Earnings Call Presentation",
      "id": 136214335,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Zoetis Inc.",
      "url": "https://finnhub.io/api/news?id=2b98da46aa6a92bfecb7ef6d510d38a3afff04b46d1d6a2d3b0acafd2ad10d61"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript",
    "summary": "Zoetis Inc. (NYSE:ZTS) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ETCompany ParticipantsKristin C.",
    "url": "https://finnhub.io/api/news?id=32c31de2dbaca9fef6915c102b42827a5fe3ea5b4f7f0e5e33413919514d3b86",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754396444,
      "headline": "Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript",
      "id": 136214336,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "Zoetis Inc. (NYSE:ZTS) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ETCompany ParticipantsKristin C.",
      "url": "https://finnhub.io/api/news?id=32c31de2dbaca9fef6915c102b42827a5fe3ea5b4f7f0e5e33413919514d3b86"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates",
    "summary": "Zoetis (ZTS) delivered earnings and revenue surprises of +8.64% and +2.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=d4764930d708b0229b77ebe87354e9da8c0c6ef965886fcefb2860dce90b4d33",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754395804,
      "headline": "Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates",
      "id": 136212545,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Zoetis (ZTS) delivered earnings and revenue surprises of +8.64% and +2.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=d4764930d708b0229b77ebe87354e9da8c0c6ef965886fcefb2860dce90b4d33"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars",
    "summary": "Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue to be around $9.53 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 9.2% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=675db2343164bf3f5167c5f53af26b3a78e0c72ac1021e5b81d1c23adfd942fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754395183,
      "headline": "Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars",
      "id": 136212546,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue to be around $9.53 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 9.2% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=675db2343164bf3f5167c5f53af26b3a78e0c72ac1021e5b81d1c23adfd942fa"
    }
  },
  {
    "ts": null,
    "headline": "1 Top Dividend Growth Stock to Buy and Hold Forever",
    "summary": "The demand for this company's products will continue increasing.",
    "url": "https://finnhub.io/api/news?id=5f6b310f197144f16b541c25311c9879b275729e28b907dabcfa3c7ee6203432",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754393400,
      "headline": "1 Top Dividend Growth Stock to Buy and Hold Forever",
      "id": 136212547,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "The demand for this company's products will continue increasing.",
      "url": "https://finnhub.io/api/news?id=5f6b310f197144f16b541c25311c9879b275729e28b907dabcfa3c7ee6203432"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Growth And Income Managed Account Q2 2025 Commentary",
    "summary": "The Portfolio returned 14.92% (gross) and the S&P 500Â® Index returned 10.94%.",
    "url": "https://finnhub.io/api/news?id=a3a6d3076bc76f630e7da38719471913e28e94a9639ea7ff136704dcb6ab0a4d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754392440,
      "headline": "Janus Henderson Growth And Income Managed Account Q2 2025 Commentary",
      "id": 136214033,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2043764026/image_2043764026.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "The Portfolio returned 14.92% (gross) and the S&P 500Â® Index returned 10.94%.",
      "url": "https://finnhub.io/api/news?id=a3a6d3076bc76f630e7da38719471913e28e94a9639ea7ff136704dcb6ab0a4d"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis: Q2 Earnings Snapshot",
    "summary": "The Parsippany, New Jersey-based company said it had profit of $1.61 per share. Earnings, adjusted for non-recurring costs, came to $1.76 per share. The results beat Wall Street expectations.",
    "url": "https://finnhub.io/api/news?id=28b95ea24f61d87abd30a1769031a7c18b613e42dce07fc4ae89b708c7873a24",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754392045,
      "headline": "Zoetis: Q2 Earnings Snapshot",
      "id": 136212548,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "The Parsippany, New Jersey-based company said it had profit of $1.61 per share. Earnings, adjusted for non-recurring costs, came to $1.76 per share. The results beat Wall Street expectations.",
      "url": "https://finnhub.io/api/news?id=28b95ea24f61d87abd30a1769031a7c18b613e42dce07fc4ae89b708c7873a24"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook",
    "summary": "PARSIPPANY, N.J., August 05, 2025--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2025 and raised its full year 2025 guidance.",
    "url": "https://finnhub.io/api/news?id=859a82cdbbba826926f47d894386fce558c16d1226820d759175d39814513e2e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754391600,
      "headline": "Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook",
      "id": 136212549,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "PARSIPPANY, N.J., August 05, 2025--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2025 and raised its full year 2025 guidance.",
      "url": "https://finnhub.io/api/news?id=859a82cdbbba826926f47d894386fce558c16d1226820d759175d39814513e2e"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Growth And Income Fund Q2 2025 Commentary",
    "summary": "The Fund returned 14.81%, and the S&P 500Â® Index returned 10.94%.",
    "url": "https://finnhub.io/api/news?id=d698f4ce822bc17e47b732ec6b11c5b90e16e53bdfec1cd75daa5771aead606d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754389620,
      "headline": "Janus Henderson Growth And Income Fund Q2 2025 Commentary",
      "id": 136213506,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2039336845/image_2039336845.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "The Fund returned 14.81%, and the S&P 500Â® Index returned 10.94%.",
      "url": "https://finnhub.io/api/news?id=d698f4ce822bc17e47b732ec6b11c5b90e16e53bdfec1cd75daa5771aead606d"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Futures Climb in Premarket Trading; Vertex Pharmaceuticals, Gartner Lag",
    "summary": "S&P 500 Futures Climb in Premarket Trading; Vertex Pharmaceuticals, Gartner Lag",
    "url": "https://finnhub.io/api/news?id=46df4155b98e5c9cf4fa4c3fba9477430adbe20838109c73d2f4ae00f2440567",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754379060,
      "headline": "S&P 500 Futures Climb in Premarket Trading; Vertex Pharmaceuticals, Gartner Lag",
      "id": 136253495,
      "image": "",
      "related": "ZTS",
      "source": "MarketWatch",
      "summary": "S&P 500 Futures Climb in Premarket Trading; Vertex Pharmaceuticals, Gartner Lag",
      "url": "https://finnhub.io/api/news?id=46df4155b98e5c9cf4fa4c3fba9477430adbe20838109c73d2f4ae00f2440567"
    }
  }
]